From “Vital Signs” in ACEP News
Source: Verispan
Zithromax Z-Pak: 961 million
Levaquin: 662 million
Zithromax suspension: 354 million
Zithromax: 310 million
Lipitor: 308 million
Norvasc: 197 million
Ambien: 191 million
Skelaxin: 189 million
Prevacid: 186 million
Toprol XL: 183 million
Filed under: Uncategorized





